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Background: Reprogramming of energy metabolism of malignant cancer cells confers competitive advantage in
growth environments with limited resources. However, not every process of cancer development is associated with
competition for resources. During hematogenous transport, cancer cells are exposed to high levels of oxygen and
nutrients. Does energy metabolism of cancer cells change as a function of exposure to the bloodstream? Could
such changes be exploited to improve the detection of circulating tumor cells (CTC)? These questions have clinical
significance, but have not yet been sufficiently examined.
Methods: The energy metabolism was examined as a function of incubation in nutrient-rich plasma in prostate
metastatic cancer cells LNCaP and non-transformed prostate epithelial cells RWPE1. Uptake kinetics of a fluorescent
glucose analog (2-NBD) and lipophilic dyes (DiD & Bodipy) were measured in both cell lines, as well as in peripheral
blood mononuclear cells (PBMC).
Results: LNCaP cells exhibited hyper-acetylation of low molecular weight proteins compared to RWPE1 cells.
Following plasma incubation, protein lysine acetylation profile was unchanged for LNCaP cells while significantly
altered for RWPE1 cells. O-linked glycosylated protein profiles were different between LNCaP and RWPE1 cells
and varied in both cell lines with plasma incubation. Maximal respiration or glycolytic capacities was unchanged
in LNCaP cells and impaired in RWPE1 cells following plasma incubation. However, the uptake rates of 2-NBD
and DiD were insufficient for discrimination of LNCaP, or RWPE1 cells from PBMC. On the other hand, both RWPE1
and LNCaP cells exhibited intracellular lipid bodies following plasma incubation; whereas, PBMC did not. The
presence of lipid bodies in LNCaP cells permitted retention of Bodipy dye and allowed discrimination of LNCaP
cells from PBMC with flow cytometry.
Conclusions: Despite clear differences in energy metabolism, metastatic prostate cancer cells could not be
efficiently distinguished from non-transformed prostate epithelial cells using fluorescent glucose or lipid uptake
kinetics. However, metastatic prostate cancer cells in plasma could be clearly distinguished from blood nucleated
cells due to the presence of intracellular lipid bodies. Fluorescent labeling of lipid bodies permitted a simple and
sensitive means for high throughput detection of metastatic prostate cancer cells in human plasma.
Keywords: Cancer energy metabolism, Coherent anti-Stokes Raman microscopy, Circulating tumor cell, Flow cytometry,
Lipid bodies, Prostate cancer, Protein lysine acetylation, Protein O-linked glycosylation, ProteomicsBackground
Reprogramming of cellular energy metabolism is a dis-
tinctive hallmark of malignant transformation [1]. Many
cancerous cells are reliant on glycolysis rather than
mitochondrial respiration for energy metabolism even in
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stated.as aerobic glycolysis or Warburg’s effect to honor the ob-
servation first described by biochemist Otto Warburg in
the early half of the 20th century [3]. The precise cause of
aerobic glycolysis is still under investigation. However, sus-
tained aerobic glycolysis is associated with the activation
of oncogenes or loss of tumor suppressors [4]. Cellular en-
ergy metabolism pathway is intrinsically and dynamically
linked to nutrient-sensing and signaling pathways. There-
fore, reprogramming of cellular energy metabolism duringd. This is an Open Access article distributed under the terms of the Creative
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nutrient-sensing and signaling pathway [5].
In the presence of oxygen, normal cells prefer oxida-
tive phosphorylation over glycolysis to maximize ATP
production per glucose molecule [6]. Under hypoxic
condition, normal cells undergo lactic acid fermentation,
or anaerobic glycolysis, where glucose is converted to
energy and lactate. Hypoxic regions of a tumor mass
arise due to high rates of cell proliferation and insuffi-
cient blood supply [7]. Hypoxic adaptation is critical for
the survival and growth of a tumor [8]. While aerobic
glycolysis is an inefficient means to generate ATP, it
facilitates the accumulation of biomass essential for cell
proliferation [6]. Aerobic glycolysis confers competitive
advantage for cancer cells in a growth environment with
limited resources [8]. Hypoxic adaptation of cancer cells
persists even in the condition of oxygen abundance [9].
However, not every process of cancer development is
associated with competition for resources. A critical step
of cancer metastasis is hematogenous transport, where
CTC are exposed to high levels of oxygen and nutrients
[10]. Cancer metastasis is the primary cause of cancer-
specific mortality [11,12]. CTC are promising thera-
peutic targets for the prevention of cancer mortality
because they are highly accessible to anti-cancer pharma-
ceutical compounds [13]. Enumeration of CTC is being
pursued as a means to monitor cancer progression and
response to therapy [14]. Yet it is not clear how meta-
static cancer cells, which have re-programed cellular
energy metabolism for adaptation to hypoxic condition,
deal with an environment rich in nutrients and oxygen
like the bloodstream [9].
In this study, we examine nutrient-sensitive protein
post-translational modifications and bioenergetics of
LNCaP and RWPE1 cells of human prostate origin as a
function of incubation in nutrient-rich plasma. We also
examine the ability to uptake lipid and glucose of these
cell lines in plasma and compare them to PBMC. Using
this in vitro model system, we aim to infer the behavior
of prostate CTC to design effective means for prostate
CTC detection.
Methods
Cell lines and materials
LNCaP and RWPE1 cell lines were obtained from
ATCC. LNCaP cells were maintained in RPMI media
and RWPE1 cells were grown in Keratinocyte media
supplemented with bovine pituitary extract and epider-
mal growth factor (Invitrogen, Carlsbad, CA) in a hu-
midified incubator with 5% CO2. All cell culture media
were supplemented with 10% FBS. Human sodium cit-
rate pooled plasma was purchased from Bioreclamation
Inc. (Westbury, NY). The peripheral blood mononuclear
cells (PBMC) were isolated from whole heparinizedblood by Ficoll plaque gradient centrifugation; buffy coat
was collected and washed with PBS to remove platelets.
1D Western blots
Total protein extracts were separated on 10% SDS-
PAGE gels, transferred to nitrocellulose membranes,
incubated first with primary antibodies against proteins
of interest and then with secondary antibodies conju-
gated with HRP or labeled with Infrared Dye. Membranes
were stripped, and re-incubated with antibodies against
GAPDH for evaluation of loading controls. Primary anti-
bodies were anti-acetylated lysine (1:1000, Cat. No.
9441S), GAPDH (1:10,000, Cat. No. 10R-G109A), and
anti-O-linked N-acetylglucosamine (1:1000, Cat. No.
9875S) from Cell Signaling (Danvers, MA), Sigma Aldrich
(Saint Louis, MO), Fitzgerald (Acton, MA) and Thermo
Fisher Scientific (Lafayette, CO) respectively. Infrared fluo-
rescently labeled secondary antibodies conjugated with IR
dye 680 (Cat. No. 926–68070) and IR dye 800 (Cat. No.
926–32211) from LICOR Biosciences (Lincoln, NE) were
used for detection using Odyssey CLx Imager. The experi-
ments were repeated three times and one representative
experiment is shown in Figure 1. In case of anti-O-linked
N-acetylglucosamine HRP-linked IgM antibody was
provided with the kit.
2D Western blots
2D Western blots were performed by Kendrick Labora-
tories (Madison, WI). The blots were wet in 100%
methanol, rinsed briefly in Tween-20 Tris buffered saline
(TTBS), and blocked for two hours in 5% bovine serum
albumin (BSA) in TTBS. The blots were then incubated
in primary antibodies including anti-acetylated lysine
(Cat. No. 9441S) and anti-O-GlcNAc monoclonal anti-
body (Cat. No. 9875S) from Cell Signaling diluted
1:1000 in 2% BSA in TTBS overnight and rinsed 3 ×
10 minutes in TTBS. The blots were then placed in se-
condary antibody (anti-mouse IgG HRP, GE, Cat. No.
NA931V) diluted 1:2,000 in 2% BSA in TTBS for two
hours, rinsed in TTBS as above, treated with ECL, and
exposed to X-ray film. The spots to be sequenced were
excised and sent to Applied Biomics (Hayward, CA) for
protein identification with MALDI-TOF-MS.
Bioenergetics of LNCaP and RWPE1
RWPE1 and LNCaP (30,000 to 40,000) cells were plated
on the poly-D-Lysine (Sigma Aldrich-Saint Louis, MO)
coated XL24 Seahorse bioanalyzer tissue culture 24 well
plates. At 5 hours after plating, cells were incubated for
12 hours with 50% plasma or used as controls. Bio-
energetics of LNCaP/RWPE1 was determined using the
XF Cell Mito Stress Test Kit and a XF24-3 Analyzer
(Seahorse Bioscience, North Billerica, MA) following
published protocols [15]. Bioenergetics experiments
Figure 1 1D Western blots of nutrient-sensitive protein post-translational modifications. (A) Protein lysine acetylation profiles as a function
of human plasma incubation of LNCaP and RWPE1 cells. (B) Protein O-linked glycosylation profiles as a function of human plasma incubation of
LNCaP and RWPE1 cells. GAPDH serves as loading controls.
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Core Facilities. At least 48 repeated measurements were
performed per experimental condition. The concentration
of Oligomycin, Carbonyl cyanide 4-trifluoromethoxy phe-
nylhydrazone (FCCP), Rotenone and Myxothiazol used
was 0.5 μM, 0.75 μM, 0.75 μM and 0.75 μM for LNCaP
and 0.75 μM, 0.25 μM, 0.75 μM and 0.75 μM for RWPE1
respectively.
Measurement of glucose and lipid uptake
To measure glucose and lipid uptake, fluorescently
labeled glucose analogue and lipophilic dyes were used,
respectively. All dyes were purchased from Molecular
Probe (Life Technologies, Grand Island, NY). For glucose
uptake measurement, 2-NBD glucose (Cat. No. N13195)
at 12.5 μg/ml was incubated for 0 to 30 minutes at room
temperature, washed and analyzed on a C6 Accuri flow
cytometer (BD Bioscience, San Jose, CA). For lipid up-
take measurement, either DiD dye (Cat. No. V-22887)
at 1.25 μM or Bodipy FL C16 dye (Cat. No. D3821) at
1 μg/ml was used. Cells were incubated at room tem-
perature for 0 to 30 minutes, then washed and analyzed
with flow cytometry.
Immunofluorescence labeling
For flow cytometry, cells were first stained with FITC
conjugated CD45 antibody (Cat. No. 555482, BD Bio-
science), then fixed and permeabilized with Intrasure kit
(Cat. No. 641776, BD Bioscience), and finally labeledwith AlexaFluor647 conjugated pan-cytokeratin antibody
(Cat. No. 4528, Cell Signaling, Danvers, MA). For fluor-
escent imaging, cytokeratin was visualized by staining
first with unconjugated primary antibodies (Cat. No.
8018, Santa Cruz Biotechnology, Santa Cruz, CA), then
with TRITC-conjugated secondary antibodies.
Coherent anti-stokes Raman scattering (CARS) microscopy
Vibrational frequency used for lipid bodies imaging
was fixed at 2851 cm-1 using a custom-built multimodal
CARS microscope described previously [16]. CARS mi-
croscopy is a sensitive label-free method for visualization
of lipid bodies [17,18]. CARS lasers were also used
for simultaneous two-photon fluorescence imaging. Epi-
reflected signals were collected using a three-channel
detector. Bandpass filters for FITC, TRITC, and CARS were
510/42 nm, 579/34 nm, and 736/128 nm, respectively.
Results and discussion
Protein acetylation of LNCaP cells was insensitive to
plasma incubation
Protein acetylation and glycosylation are nutrient-sensitive
post-translational modifications important for the regula-
tion of cellular energy metabolism [5]. Using 1D Western
blots, protein lysine acetylation profiles of LNCaP cells
were examined following incubation with 50% human
plasma for 24 hours (Figure 1A). Surprisingly, there was no
significant change to protein acetylation profiles between
untreated and plasma treated LNCaP cells. Compared to
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proteins with low molecular weight. In contrast, non-
transformed prostate epithelial RWPE1 cells exhibited sig-
nificant changes to the protein lysine acetylation profiles
between untreated and plasma treated cells. Interestingly,
plasma treated RWPE1 cells exhibited de-acetylation of
low molecular weight proteins compared to untreated
RWPE1 cells.
Protein O-linked glycosylation of LNCaP cells was insensitive
to plasma incubation
1D Western blots were employed to examine protein O-
linked glycosylation of LNCaP cells following incubation
with 50% human plasma for 24 hours (Figure 1B). With
the exception of a slight increase in O-linked glycosyla-
tion of a protein band at 52 kD, there was no other
significant change to protein O-linked glycosylation pro-
files between untreated and plasma treated LNCaP cells.
In contrast, RWPE1 cells exhibited several significant
changes to the protein O-linked glycosylation profiles be-
tween untreated and plasma treated cells. Most notable
are the de-glycosylation of a protein band at approxi-
mately 60 kD and a protein band at 52 kD following
incubation of RWPE1 cells in 50% human plasma.
Identification of lysine acetylated proteins with proteomics
2D Western blots were employed for high resolution
analysis of protein lysine acetylation profiles (Figure 2A-D).Figure 2 2D Western blots of protein lysine acetylation profiles. Prote
cells incubated with human plasma, (C) untreated RWPE1 cells, and (D) RWCompared to RWPE1 cells, LNCaP cells exhibited protein
hyper-acetylation with significantly more immuno-positive
spots for proteins with low molecular weight of 30 kD or
less (Figure 2A, C). Plasma treatment did not significantly
change the protein lysine acetylation profile of LNCaP cells
(Figure 2A, B). In contrast, plasma treatment reduced
lysine acetylation of four low molecular weight protein
spots of RWPE1 cells (Figure 2C, D). Selective 2D gel
spots matching the positions of lysine acetylated pro-
teins were excised and used for protein identification
with matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF-MS). Identi-
fied acetylated proteins and their biological functions
are listed in Table 1 and Additional file 1: Table S1. Ex-
pectedly, a number of acetylated proteins participate
in energy metabolism pathway including mitochondrial
fatty acid β-oxidation and glycolysis. Other acetylated
proteins participate in antioxidation, stress response,
cytoskeletal structures, and other biological functions.
Interestingly, four low molecular weight protein spots
that got de-acetylated following plasma incubation in
RWPE1 cells were identified as enoyl-CoA hydratase
(mitochondrial fatty acid β-oxidation), mitochondrial
carrier homolog 2 (transport/apoptosis), actin (cytoskeletal
structure), and peroxiredoxin-4 (antioxidation). Many pro-
teins identified did not migrate with predicted molecular
weights or isoelectric points due to possible protein post-
translational modifications or degradation.in lysine acetylation profiles of (A) untreated LNCaP cells, (B) LNCaP
PE1 cells incubated with human plasma.












1 Peroxiredoxin-2 √ √ - - Antioxidation
2 Protein DJ-1 √ √ - - Stress Response
3 Thioredoxin-dependent peroxide reductase,
mitochondrial
√ √ - - Antioxidation
4 Enoyl-CoA hydratase, mitochondrial √ √ √ - Fatty Acid β-oxidation
5 Peroxiredoxin-6 √ √ - - Antioxidation
6 Triosephosphate isomerase √ √ - - Glycolysis
7 Triosephosphate isomerase √ √ - - Glycolysis
8 Phosphoglycerate mutase 1 √ √ - - Glycolysis
9 78 kDa glucose-regulated protein √ √ - - Unfolded Protein Response
10 40S ribosomal protein S8 √ √ - - Protein Synthesis
11 Prohibitin-2 √ √ - - Transcription Regulation
12 Mitochondrial carrier homolog 2 √ √ √ - Mitochondrial Transport
13 S-formylglutathione hydrolase √ √ - - Formaldehyde
Catabolism
14 Delta (3,5)-Delta (2,4)-dienoyl-CoA isomerase,
mitochondrial
√ √ - - Fatty Acid β-oxidation
15 26S proteasome non-ATPase regulatory
subunit 14
√ √ - - 26S Proteosome Assembly
16 Peroxiredoxin-4 √ √ √ - Antioxidation
17 Proteasome activator complex subunit 1 √ √ - - Cell Differentiation
18 Prohibitin √ √ √ √ DNA Synthesis
19 L-lactate dehydrogenase B chain √ √ - - Glycolysis
20 Inorganic pyrophosphatase √ √ - - Diphosphate Metabolism
21 Actin, cytoplasmic 1 √ √ √ - Cytoskeletal Structure
22 Tropomyosin alpha-3 chain √ √ - - Cytoskeletal Structure
23 40S ribosomal protein SA √ √ √ √ 40S Ribosome Assembly
24 Tropomyosin beta chain √ √ √ √ Cytoskeletal Structure
25 78 kDa glucose-regulated protein √ √ - - Unfolded Protein Response
26 Glyceraldehyde-3-phosphate dehydrogenase √ √ √ √ Glycolysis
27 Alpha enolase √ √ - √ Glycolysis
28 Calnexin √ √ √ - Calcium Binding
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with proteomics
2D Western blots were employed for high resolution
analysis of protein O-linked glycosylation profiles
(Figure 3A-D). Plasma incubation induced significant
changes to the protein O-linked glycosylation profiles
of LNCaP cells. Most notably are the de-glycosylation
of protein spots 2 and 3 of ~14 kD and glycosylation of
protein spot 7 of ~29 kD (Figure 3A, B). Plasma incu-
bation also induced significant changes to the protein
O-linked glycosylation profiles of RWPE1 cells. Most not-
ably are the de-glycosylation of protein spot 9 of ~80 kD
and the reduced glycosylation of protein spots 5 and6 of ~60 kD (Figure 3C, D). In general, RWPE1 cells
exhibited more O-linked glycosylated protein spots
than LNCaP cells. Selective 2D gel spots matching the
positions of O-linked glycosylated proteins were excised
and used for protein identification with MALDI-TOF-
MS. Identified O-linked glycosylated proteins and their
biological functions are listed in Table 2 and Additional
file 1: Table S2. For LNCaP cells, protein spots 2 and 3
were identified as histone 2B type 1-M, a component
of the nucleosome. Protein spot 7 was identified as phos-
phoglycerate mutase 1, an enzyme of the glycolytic
pathway. On the other hand, protein spot 9 of RWPE1
cells was identified as mitochondrial trifunctional enzyme
Figure 3 2D Western blots of protein O-linked glycosylation profiles. Protein O-linked glycosylation profiles of (A) untreated LNCaP cells,
(B) LNCaP cells incubated with human plasma, (C) untreated RWPE1 cells, and (D) RWPE1 cells incubated with human plasma.
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β-oxidation pathway. Protein spots 5 and 6 were iden-
tified as keratin, type II cytoskeletal 6A and 6B, re-
spectively. Proteomics data using 2D Western blots
couldn’t identify any specific protein spot at 52 kD,Table 2 Protein O-linked glycosylation as a function of plasm
Spot number Protein name LNCaP control LNCaP
1 UPF0556 protein C19orf10 √
2 Histone H2B type 1-M √
3 Histone H2B type 1-M √
4 Delta (3,5)-Delta (2,4)-dienoyl-CoA
isomerase, mitochondrial
√
5 Keratin, type II cytoskeletal 6A √
6 Keratin, type II cytoskeletal 6B √
7 Phosphoglycerate mutase 1 -
8 Elongation factor 2 -
9 Trifunctional enzyme subunit alpha,
mitochondrial
-
10 Procollagen galactosyltransferase 1 -
11 Keratin, type II cytoskeletal 7 -
12 Keratin, type I cytoskeletal 14 -
13 Keratin, type I cytoskeletal 17 -
14 Vimentin -
15 Vimentin -whose O-linked glycosylation changed as a function of
plasma incubation in 1D Western blot. It is likely that
the glycosylation profile of the 1D gel band at 52 kD
was the collective profile of multiple proteins with the
same molecular weight.a incubation
+plasma RWPE1 control RWPE1+plasma Biological function
√ - - Unfolded Protein Response
- √ √ Nucleosome Assembly
- √ √ Nucleosome Assembly
√ - - Fatty Acid Metabolim
√ √ √ Cytoskeletal Structure
√ √ √ Cytoskeletal Structure
√ - - Glycolysis
√ - - Protein Synthesis
- √ - Fatty Acid β-oxidation
- √ √ ECM Organization
- √ √ Cytoskeletal Structure
- √ √ Cytoskeletal Structure
- √ √ Cytoskeletal Structure
- √ √ Cytoskeletal Structure
- √ - Cytoskeletal Structure
Figure 4 Bioenergetics of LNCaP cells as a function of plasma incubation. (A) Real-time oxygen consumption rates (OCR) and (B) average
values of key parameters for the evaluation of mitochondrial functions of LNCaP cells. (C) Real-time extracellular acidification rates (ECAR) and
(D) average values of key parameters for the evaluation of glycolytic function of LNCaP cells. Error bars are standard deviation across 48 repeats
per experimental condition. Asterisk indicates P-value < 0.05 determined with paired Student’s t-test against untreated control.
Figure 5 Bioenergetics of RWPE1 cells as a function of plasma incubation. (A) Real-time oxygen consumption rates (OCR) and (B) average
values of key parameters for the evaluation of mitochondrial functions of RWPE1 cells. (C) Real-time extracellular acidification rates (ECAR) and
(D) average values of key parameters for the evaluation of glycolytic function of RWPE1 cells. Error bars are standard deviation across 48 repeats
per experimental condition. Asterisk indicates P-value < 0.05 determined with paired Student’s t-test against untreated control.
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cells were insensitive to plasma incubation
Bioenergetics of LNCaP and RWPE1 cells were evaluated
as a function of plasma incubation. Using an extra-
cellular flux analyzer, mitochondrial function was evalu-
ated by measuring in real time the oxygen consumption
rates (OCR) and glycolytic function was evaluated by
measuring in real time the extracellular acidification
rates (ECAR) (Additional file 1: Figure S1A, B). Incu-
bation with plasma slightly reduced ATP production
of LNCaP cells while having no statistically significant ef-
fect on their maximal mitochondrial respiration capacity
(Figure 4A, B). Incubation with plasma also slightly in-
creased glycolysis of LNCaP cells while having no statisti-
cally significant effect on their maximal glycolytic capacity
(Figure 4C, D). In contrast, incubation with plasma slightlyFigure 6 Comparison of glucose and lipid uptake between RWPE1, LN
and PBMC cells. Blue lines represent control cells without incubation with n
incubated with either fluorescent glucose analog (A) or DiD (B). Dashed lin
that separate stained cells from unstained cells. Cut-off values were chosen
plasma for 16 hours, then with fluorescent glucose analog or with lipop
cytometry experiment. (C) and (D) are graphical presentation of average
for glucose and lipid uptake, respectively. Error bars are standard deviatio
determined with paired Student’s t-test against untreated control.reduced ATP production of RWPE1 cells while severely
reduced their maximal mitochondrial respiration capacity
by over 50% (p-value <0.05) (Figure 5A, B). Incubation
with plasma also reduced both the average glycolysis rate
and maximal glycolytic capacity of RWPE1 cells by over
30% (p-value <0.05) (Figure 5C, D).
Plasma incubation repressed glucose uptake and
enhanced lipid uptake of LNCaP cells
Next, glucose and lipid uptake of LNCaP cells were evalu-
ated using a fluorescent glucose analog and a lipid stain
dye (DiD) and conventional flow cytometry. The difference
between glucose and lipid uptake of LNCaP cells, RWPE-1
cells, and peripheral blood mononuclear cells (PBMC)
was also evaluated to determine whether such difference
could be exploited for their detection (Figure 6A, B).CaP and PBMC. (A) Glucose and (B) lipid uptake of LNCaP, RWPE1
either fluorescent glucose analog nor DiD. Red lines represent cells
es with bar heads indicate the cut-off fluorescence intensity values
to exclude >95% of control unstained cells. Cells were incubated with
hilic DiD dye for 15 minutes. Data presented are of one set of flow
flow cytometry data of at least 4 repeats per experimental condition
n across 4 repeated measurements. Asterisk indicates P-value < 0.05
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fluorescent glucose analog of more than 90% in LNCaP
cells and less than 30% of RWPE1 cells (Figure 6C,
Additional file 1: Figure S2, Additional file 1: Figure S3).
Nearly 70% of PBMC exhibited uptake of the fluorescent
glucose analog. In contrast, plasma incubation enhanced
DiD staining of LNCaP cells by 14% (86% staining
without plasma incubation versus 100% staining with
plasma incubation) (Figure 6D, Additional file 1: Figure S4,
Additional file 1: Figure S5). On the other hand, plasma
incubation repressed DiD staining of RWPE1 cells by
approximately 17%. Nearly 80% of PBMC stained posi-
tively with DiD (Figure 6B, Additional file 1: Figure S6).
Our data revealed that plasma incubation repressedFigure 7 Effect of fixation on lipophilic dye retention in LNCaP and P
for 5 min, after labeling half of the cells were fixed and permeabilized using
antibody tagged with Alexa647 for 30 min at room temperature. (B) Blue lin
immunolabeled with pan-cytokeratin antibody tagged with Alexa 647.
or immunolabeled with pan-cytokeratin antibody tagged with Alexa 647. (C
Data presented are of one set of flow cytometry experiments. (D) The avera
indicates P-value < 0.05 determined with paired Student’s t-test against untrglucose uptake of LNCaP cells while enhanced their
lipid uptake.
Bodipy staining of LNCaP cells was preserved after
fixation and permeabilization
To improve lipid staining, DiD was replaced with
Bodipy, a fluorescent fatty acid analog that undergoes na-
tive like transport and metabolism. Using flow cytometry,
we found that both LNCaP cells (incubated over night
with plasma) and PBMC achieved nearly 100% staining
with Bodipy after 5 minutes of staining (Figure 7A).
However, after fixation and permeabilization, Bodipy
staining was retained for more than 90% of LNCaP cells
compared to less than 20% of PBMC. A second stain withBMC cells. (A) Both LNCaP and PBMC cells were labeled with Bodipy
intrasure kit. (B) Permeabilized cells were labeled with pan-cytokeratin
es represent LNCaP or PBMC cells without staining with Bodipy FL or
Red lines represent LNCaP or PBMC cells stained with Bodipy FL
) Two-color flow cytometry data for dual-stained LNCaP and PBMC cells.
ge values of four experiments are shown in a graphical format. Asterisk
eated control.
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up to 90% of LNCaP cells and only 5% of PBMC were
stained positively for both Bodipy and cytokeratin follow-
ing fixation and permeabilization protocol (Figure 7B, C).
Clearly, while both LNCaP cells and PBMC exhibited
strong affinity for Bodipy, only cytokeratin-positive
LNCaP cells were able to significantly retain Bodipy after
fixation and permeabilization.
Formation of lipid bodies in LNCaP cells following plasma
incubation
Widefield fluorescent microscopy confirmed the ability
to retain Bodipy staining after fixation and permea-
bilization of LNCaP cells and lack-there-of in PBMC
(Figure 8A). Interestingly, Bodipy staining revealed
granulated structures in the cytoplasm of LNCaP cells.
Using coherent anti-Stokes Raman scattering (CARS)
microscopy, a label-free imaging technique for lipid
visualization [17], and two-photon fluorescent (TPF)
microscopy, we observed the present of lipid bodies in
LNCaP cells but not in PBMC (Figure 8B). Taken to-
gether, our data revealed that Bodipy was taken up by
both LNCaP cells and PBMC along with plasma lipids.
However, only in LNCaP cells did Bodipy and plasma
lipids formed into lipid bodies. These lipid bodies
remained within LNCaP cells even after cell fixation
and permeabilization. In contrast, Bodipy and plasmaFigure 8 Visualization of lipid bodies in LNCaP cells. (A) Widefield fluo
for lipid bodies and Hoechst (blue) for nuclei. (B) CARS (red) images of
immunofluorescently labeled LNCaP cells (yellow) and PBMC cells (green). L
against cytokeratin (CK). PBMC cells were identified with FITC conjugated prlipids did not form into lipid bodies in PBMC, thus, es-
caped PBMC following cells fixation and permeabilization
(Figure 8B & Figure 7D). The difference in the ability to
form lipid bodies between LNCaP cells and PBMC permits
clear differentiation of these cell types through the use of a
fluorescent fatty acid analog Bodipy.
Formation of lipid bodies in both RWPE1 and LNCaP cells
following plasma incubation
Both RWPE1 and LNCaP cells accumulated intracellular
lipid bodies after incubation with plasma (Additional file 1:
Figure S7) [19]. The presence of lipid bodies caused lipo-
philic stains, such as Bodipy (data not shown) and Oil Red
O, to remain even after cell fixation in both RWPE1 and
LNCaP cells. Therefore, the use of lipid staining together
with cell fixation and permeabilization did not permit the
differentiation of RWPE1 from LNCaP cells.
Conclusions
In this study, we reported that nutrient-sensing mech-
anism and bioenergetics of metastatic prostate LNCaP
cells were insensitive to plasma incubation. Compared
to non-transformed prostate epithelial RWPE1 cells,
LNCaP cells exhibited hyper-acetylation of proteins with
low molecular weights. These proteins participate in vital
functions including mitochondrial fatty acid β-oxidation,
transport, cytoskeletal structure, and antioxidation. Plasmarescent images of LNCaP and PBMC cells stained with Bodipy (green)
lipid bodies and two-photon fluorescence (yellow, green) images of
NCaP cells were identified with TRITC conjugated primary antibodies
imary antibodies against CD45.
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of LNCaP cells while significantly altered those of RWPE1
cells. On the other hand, LNCaP cells exhibited reduced
O-link glycosylation of many cytoskeletal proteins com-
pared to RWPE1. Plasma incubation reduced O-link glyco-
sylation of histone H2B proteins while increased O-linked
glycosylation of a glycolytic protein phosphoglycerate
mutase 1 in LNCaP cells. In contrast, plasma incubation
of RWPE1 cells exhibited reduced O-link glycosylation of
cytoskeletal proteins keratin type 2 and a mitochon-
drial trifunctional enzyme, a protein critical for fatty acid
β-oxidation. Plasma incubation did not affect maximal
respiration and glycolytic capacities of LNCaP cells while
significantly reduced these capacities of RWPE1 cells. In
summary, bioenergetics and protein lysine acetylation
profiles of LNCaP cells were less sensitive to plasma
incubation compared to RWPE1 cells.
We also evaluated whether the difference in nutrient
sensing and bioenergetics between LNCaP cells and
RWPE 1 cells could affect their uptake kinetics of glu-
cose and lipid. Following plasma incubation, uptake kin-
etics of a fluorescent glucose analog was significantly
diminished in LNCaP cells but not in RWPE1 cells. In
contrast, fluorescent lipid staining improved for LNCaP
cells and declined for RWPE1 cells following plasma
incubation. Nonetheless, the difference in glucose and
lipid uptake kinetics between LNCaP and RWPE1 cells,
with and without plasma incubation, were insufficient to
be used for the discrimination of one cell type against
the other. Our data concurred with an independent
study where the uptake rates of glucose and palmitate
were found to be comparable for malignant and benign
prostate cell lines [20]. Thus, the affinity for glucose and
lipids of LNCaP cells and RWPE1 cells did not mirror their
clear difference in nutrient sensing and bioenergetics.
Increased affinity for lipid by LNCaP cells in plasma
presents a unique opportunity for its detection. Interest-
ingly, we observed that cell fixation and permeabilization
following lipid staining permitted differentiation of
LNCaP cells from PBMC. Both LNCaP cells and PBMC
exhibited high lipid uptake rates as shown in this study
and the literature [20-22]. However, cell fixation and
permeabilization significantly reduced lipid staining of
PBMC while only slightly reduced lipid staining of
LNCaP cells. Consequently, LNCaP cells exhibited sig-
nificantly higher lipid staining than PBMC. A key con-
tributor to this observation was the presence of lipid
bodies in LNCaP cells and lack-there-of in PMBC, which
permitted retention of lipid stain following cell fixation
and permeabilization. Compared with cytokeratin, a
marker for prostate and epithelial cells, Bodipy lipid
stain was equally effective in differentiating LNCaP cells
from PBMC using both flow cytometry and fluorescence
microscopy.Lipid staining provides a simple means for high
throughput detection of cancer cells in plasma. Previ-
ously, we reported label-free detection with CARS mi-
croscopy of lipid-rich prostate CTC in the peripheral
blood samples of metastatic prostate cancer patients
[19]. Accumulation of lipid bodies in cancer cells ex-
posed to blood plasma appears to be a conserved pro-
perty for various type of cancer cells of epithelial origins
[19,23]. CARS microscopy is ideal for the detection of
lipid-rich cells [24]. In recent years, CARS microscopy
has been increasingly employed for imaging of primary
tumors [25-30]. However, CARS microscopy is currently
not yet available for clinical applications due to its large
footprint, operation complexity, and high cost [18]. In
contrast, flow cytometry and fluorescent microscopy are
now available in most clinical pathology laboratories.
Simple lipid staining of peripheral blood samples of
cancer patients could provide a rapid means for initial
screening for the presence of CTC. Future multicolor
combinatorial staining of various markers including lipid,
cytokeratin, CD45, epithelial cell adhesion molecule,
could improve sensitivity and accuracy for CTC detection
using flow cytometry and microscope-based cytometry.Additional file
Additional file 1: Table S1. Lysine acetylated proteins identified with
MALDI-TOF-MS. Table S2. O-linked glycosylated proteins identified with
MALDI-TOF-MS. Figure S1. Graphical representation of measurements for
energy metabolism. (A) Schematic depiction of how basal and maximum
respiration values are calculated (B) schematic display to show the
calculation of glycolysis and maximum glycolysis. Figure S2. Glucose uptake
kinetics of LNCAP cells. Time course of (0-30 min) of glucose analog uptake
kinetics is shown with and without plasma incubation. Data presented are
from one single flow cytometry measurement per experimental condition.
Figure S3. Glucose uptake kinetics of RWPE-1 cells. Time course of (0-30 min)
of glucose analog uptake kinetics is shown with and without plasma
incubation. Data presented are from one single flow cytometry measurement
per experimental condition. Figure S4. Lipid uptake kinetics of LNCAP cells.
Time course of (0-30min) of DiD uptake kinetics is shown with and without
plasma incubation. Data presented are from one single flow cytometry
measurement per experimental condition. Figure S5. Lipid uptake kinetics
of RWPE-1 cells. Time course of (0-30 min) of DiD uptake kinetics is shown
with and without plasma incubation. Data presented are from one single
flow cytometry measurement per experimental condition. Figure S6.
Uptake kinetics of PBMCs for glucose (A) and lipids (B). Time courses
of (0-30 min) for fluorescent glucose analog and lipophilic DiD dye uptake
kinetics are shown. Data presented are from one single flow cytometry
measurement per experimental condition. Figure S7. Lipid droplet
accumulation in RWPE1 and LNCaP cells following plasma incubation. RWPE1
and LNCaP cells were incubated for 12 hours with 50% plasma, then fixed,
permeabilized and stained with Oil Red O.
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